|
|
FEBRUARY 2025
|
|
|
IN THIS NEWSLETTER:
- From the Cancer Consortium
- Consortium Kudos
- Current Funding Opportunities
- Save the Date - Upcoming Events
- From the Office of Community Outreach & Engagement
- From the Consortium Shared Resources
- From the Office of Translational Research
|
|
|
|
FROM THE CANCER CONSORTIUM
|
|
|
|
Consortium Kudos
Dr. Kemi Doll Awarded 2025 Martin Luther King Jr. Community Service Award
Congratulations to Dr. Kemi Doll, who was awarded the 2025 Martin Luther King Jr. Community Service Award! This award, which is conferred by the University of Washington Medical Center, recognizes members of the UW community who are committed to addressing community needs, improving the human condition, and protecting and empowering all individuals.
“I am so grateful and honored to be highlighted for this recognition,” said Dr. Doll. “The Rev. Dr. King was a towering figure of courage and example of service in our society and I am moved that the work we do can be seen in this light.”
Dr. Kemi Doll is a gynecologic oncologist and professor at UW. Her research focuses on improving outcomes for Black/African American and White women experiencing gynecologic diseases, especially endometrial cancer. In 2017, she co-founded the Endometrial Cancer Action Network for African-Americans (ECANA), the nation's first endometrial cancer advocacy organization for Black women. She is currently the founding director of the Gynecologic Research And Cancer Equity (GRACE) Center at the UW.
The theme for this year’s Community Service Awards is “Rising Up to the Challenge: Uniting for Freedom, Justice and Democracy.” Dr. Doll was selected for this award for her tireless efforts to understand and find solutions for racial health disparities, her advocacy work for public policies and interventions to improve health outcomes for Black women, and her support and mentorship for other women of color in STEM fields.
Dr. Doll is a member of the Cancer Consortium's Breast & Ovary Cancers program.
Please join us in congratulating Dr. Doll!
|
|
|
|
|
CURRENT FUNDING OPPORTUNITIES
|
Cancer Consortium Pilot Awards
Funds are available from the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium (“the Consortium”) to support cancer-related pilot projects. This competition will provide 3-4 awards of up to $100,000 direct costs (plus F&A/indirect costs) for one year of pilot project support. All Consortium members are eligible for this pilot funding.
There are no limitations on research topic, provided the problem under study is focused on cancer. Highly innovative concepts that have the potential to improve the lives of cancer patients are encouraged. Also included in this competition are two categories targeted as areas of special interest to the Consortium: health equity research and cross-disciplinary translational research.
For more information about eligibility, application requirements, and more, please see the RFA ( click here). Applications are due February 14th, 2025, by 5:00pm PST.
|
Catchment Area Health Pilot Awards
Funds are available from the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium ("the Consortium") Cancer Center Support Grant (CCSG) and non-sponsored funds to support new cancer-related pilot projects focused on the Consortium’s catchment area, which includes the entire state of Washington. The research plan should address research on cancers relevant to the catchment area and/or the populations that face the highest burden or cancer disparities in the state. This competition will fund one project, at a maximum of up to $100,000 in direct costs (plus F&A/indirect costs), for one year.
For more information about eligibility, application requirements, and the cancer burden in Washington, please see the RFA ( click here). Applications are due February 14th, 2025, by 5:00pm PST.
|
|
|
|
|
|
|
UPCOMING EVENTS
|
» [Ongoing] Steam Plant Seminar Series
Please join us in the Steam Plant O’Mack Suites (Fred Hutch Campus) at 4pm on Wednesdays for a seminar series organized by Steam Plant trainees.
- February 5: Hugh Haddox (Matsen Lab)
- February 12: Sara Becker (Blanco Melo Lab)
- February 19: Rachael Adams (Hill Lab)
- February 26: Anna Elz (Fred Hutch Innovation Lab)
- March 5: Mikel Ruterbusch (Veatch Lab)
- March 12: TBD (Setty Lab)
- March 19: Mark Mendoza (Furlan Lab)
- March 26: Iyabode Tiamiyu (Warren Lab)
A schedule of talks can be found on the Steam Plant’s Community CenterNet site ( *requires FH credentials). To receive notifications, please join the mailing list at https://lists.fhcrc.org/postorius/lists/steamplant-seminar.lists.fhcrc.org/. You will need to copy and paste this link into your browser, if using a Mac. If you are working remotely, you will need to be on VPN to access the listserv.
|
» [Ongoing] Monthly Shared Resources Seminar Series
Please join the shared resources team for their new monthly seminar series. Each hour-long seminar will be presented by a different shared resource, and will focus on a topic pertinent to the work of that core.
Upcoming Seminar Dates:
- February 12 (11:30am): "Preclinical Positron Emission Tomography and Computed Tomography (PET/CT) Imaging at UW," hosted by Translational Bioimaging (D1-080, Sze Suites, Fred Hutch Campus)
- March 12 (11:30am): Topic TBD, hosted by Preclinical Imaging (D1-080, Sze Suites, Fred Hutch Campus)
- April 9 (11:30am): "DNA and RNA Sequencing Methods," hosted by Genomics & Bioinformatics (D1-080, Sze Suites, Fred Hutch Campus)
Click here to sign up for the upcoming February seminar.
All seminars are hybrid. Attendees will receive a Teams link once they sign up. Please contact Tony Bohn ( abohn@fredhutch.org) with any questions.
|
» February 28: Stuart and Molly Sloan Precision Oncology Institute Theranostics Symposium
Join us on February 28th, 2025, at Fred Hutch Cancer Center for a symposium to explore the field of theranostics. Theranostics is a cutting-edge approach in precision medicine that merges diagnostics with therapeutics and holds great promise for improving patient outcomes in oncology. The Theranostics Symposium is organized in partnership with UW Radiology and co-hosted by Drs. Amir Iravani, Director of Theranostics, and Delphine Chen, Director of Molecular Imaging and Therapy, Fred Hutch Cancer Center.
Drs. Iravani and Chen have invited a panel of local and national leaders in the field to deliver talks and join in discussion on the latest advances in theranostics. Following talks, all attendees are welcome to meet the speakers and enjoy a selection of food and beverages at a reception from 3:40-4:30pm in the Weintraub B-Suites.
- Date: Friday, February 28th, 2025
- Time: 8:30am-3:30pm
- Location: Pelton Auditorium, Weintraub Building, Fred Hutch Cancer Center (1100 Fairview Ave N)
- Reception: 3:40-4:30 pm in Weintraub B-Suites
|
» March 5: Pathogen Associated Malignancies (PAM) Integrated Research Center (IRC) Seminar
Join us for another PAM IRC seminar! This seminar will take place at 2pm on Wednesday, March 5 th, in Pelton Auditorium (Fred Hutch Campus) or virtually via Zoom ( click here to join).
Our guest speaker will be Timothy Hand, PhD (Associate Professor, University of Pittsburgh) who will give a presentation titled, "Maternal antibodies regulate the development of the pediatric microbiome and immune system."
|
» May 1: STTR Innovation Retreat 2025 - Save the Date + Call for Poster Submissions!
The Office of Translational Research is proud to host the next Seattle Translational Tumor Research (STTR) Retreat, bringing together a network of researchers and clinicians for an engaging and collaborative event. The event will take place on Thursday, May 1st, at the Museum of Flight. The theme for the retreat is "Innovation." The event will feature scientific talks, a poster session, and a late afternoon reception.
We invite STTR members, postdocs, and trainees to present their research in the poster session. This is a great opportunity to share your work with the community, engage in meaningful discussions, and receive valuable feedback from peers and experts. To participate, please submit your poster title and abstract to STTRCancer@fredhutch.org by March 14th. Due to space constraints, we are only able to accept a limited number of posters. Selected presenters will be notified by email.
|
» May 6: Pathogen Associated Malignancies (PAM) Integrated Research Center (IRC) and Microbiome Research Initiative Joint Retreat - Save the Date!
Join us for the 2025 Joint Retreat of the PAM IRC, the Cancer Consortium's Pathogen Associated Malignancies PAM Research Program, and the Microbiome Research Initiative. This event will take place on Tuesday, May 6th, 2025, at Fred Hutch Cancer Center, and is open to all Consortium members, including trainees and staff. This year's event will feature the following keynote speakers:
- Eric Engles, MD, PhD, Director & Senior Investigator, Infections and Immunoepidemiology Branch, NIH
- Sean Gibbons, PhD, Associate Professor, Institute for Systems Biology
Registration will open soon. In the meantime, please contact Marcie Dominguez ( mdomingu@fredhutch.org) with any questions.
|
|
» May 13: Pathways to Equity Symposium
You are invited to the 2025 Pathways to Equity Symposium!
- Date: Tuesday, May 13th, 2025
- Time: 8:30 am – 4:00 pm PST
- Location: Fred Hutch Campus and streaming online
This annual event is hosted by the Office of Community Outreach and Engagement and brings together researchers, community members, and providers to learn best practices and share experiences to address cancer inequities.
This year’s theme is "Mountains, Valleys, and Islands: Bridging Access to Care in Washington State" with a keynote address by Yamilé Molina, PhD, MS, MPH, from the University of Illinois Chicago.
Nominations are also open for the Health Equity Champion Awards. Please visit the OCOE Awards Page for award information and to submit a nomination by March 28th.
More information and a preview agenda will be coming soon. This event is free, and lunch will be provided to those attending in person. Click here to register.
|
» June 19-21: 4th International Symposium on Late Complications after Childhood Cancer (ISLCCC)
Please join us this summer for the 4th ISLCCC Conference, hosted by the Fred Hutch Survivorship Program. This in-person event will take place at the Bell Harbor International Conference Center in Seattle.
The 2025 symposium will provide a venue for the multidisciplinary exchange of innovative ideas among clinicians and researchers engaged in pediatric and adolescent cancer survivorship care and research. This year's topics will include emerging research results and insights from real-word clinical experience to promote research collaborations and improve survivorship care throughout the world, and will include the following keynote presentations and panels:
- Dr. Les Robison (St. Jude Children's Research Hospital): "Ann Mertens & Marilynn Stovall memorial lecture on childhood cancer survivorship, past, present, and future."
- Dr. Joshua Hill (Fred Hutch Cancer Center): "Immune reconstitution following cancer therapy."
- Dr. Angela Bradbury (University of Pennsylvania): “Cancer predisposition and genetic considerations in long-term cancer survivors."
- Dr. Ruth Etzioni (Fred Hutch Cancer Center): “Current evidence and future implementation of multi-cancer detection screening."
- Panel: "Transition of AYA survivors to adult care."
- Panel: "Development of survivorship care and research in LMIC settings."
The meeting will immediately follow the Childhood Cancer Survivor Study (CCSS) Investigators' Meeting and a meeting of the International Guideline Harmonization Group (IGHG).
Registration is now open for ISLCCC 2025. Click here to register.
|
» June 27: Dr. Rainer Storb Symposium - Save the Date!
Please save the date for a scientific symposium and reception in honor of the career and accomplishments of Dr. Rainer Storb! We look forward to hearing from Dr. Storb’s colleagues and trainees as they speak on topics in transplantation. This event will take place at the Fred Hutch South Lake Union Campus.
|
|
|
|
|
|
|
FROM THE OFFICE OF COMMUNITY OUTREACH & ENGAGEMENT
|
Call for Mentors and Reviewers for the 2025 Community Grants Program
This small grants program supports community-based organizations and Tribes working toward health equity in diverse communities across Washington State. Mentors are matched with applicants to help develop or review proposal drafts. Reviewers will then evaluate and score submitted projects.
Eligibility and Time Commitment:
|
|
|
|
Stay Up to Date on All Things OCOE!
Did you know the OCOE has a newsletter? Click here to view past editions or subscribe to our mailing list and stay connected to all our health equity initiatives!
|
|
|
|
|
|
|
FROM THE CONSORTIUM SHARED RESOURCES
|
|
Nanopore Sequencing in Genomics and Bioinformatics Shared Resource
The Genomics and Bioinformatics Shared Resource (G&BSR) is pleased to announce that we have acquired an Oxford Nanopore Technologies P2 Solo sequencing system. This sequencing technology provides cost-effective long-read sequencing to support a variety of applications, including whole genome sequencing, long-read RNA sequencing, whole plasmid sequencing, microbial genome sequencing, and direct RNA sequencing. Additionally, this technology enables direct methylation detection. The P2 Solo can run two PromethION flow cells in parallel. Each PromethION flow cell can output >100 Gb per 72-hour run.
The G&BSR is offering library preparation using the Native Barcoding Kit (ligation) and Rapid Barcoding (tagmentation) kits and are also providing sequencing-only services for user-prepared libraries. Additionally, we can support bioinformatic analysis, using the pipelines contained in the EPI2ME software suite. Contact us today at Genomics@fredhutch.org to discuss your project.
|
|
|
|
FROM THE OFFICE OF TRANSLATIONAL RESEARCH
|
STTR Translational Research Awards
Congratulations to the winners of the 2024 STTR Innovative Translational Research Partnerships Grants! These competitive awards support innovative translational research projects through interdisciplinary collaboration, with strong potential for future external funding and scientific impact.
OTR extends our gratitude to all applicants and reviewers who participated in this rigorous selection process. These projects were selected through a competitive review process, and we look forward to seeing their impact on cancer research. Please join us in celebrating our awardees:
- Dr. Evan Newell for his proposal titled "Exploiting the surgical wound healing response to target residual breast cancer."
- Drs. Marie Bleakley and Shannon Oda for their proposal titled "Eradicating AML with engineered T-cells."
The STTR team is excited to support these projects in support of advancing translational research at Fred Hutch and across the Cancer Consortium.
|
|
|
|
|
|
FRED HUTCH/UNIVERSITY OF WASHINGTON/SEATTLE CHILDREN'S CANCER CONSORTIUM
1100 FAIRVIEW AVE. N., SEATTLE, WA 98109
Award number P30 CA015704-49
|
|
|
|
|